• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.

作者信息

Kurz P, Tsobanelis T, Brunkhorst R, Roth P, Werner E, Schoeppe W, Vlachojannis J

机构信息

KfH-Dialysezentrum, Frankfurt, Germany.

出版信息

Perit Dial Int. 1997 Jan-Feb;17(1):59-65.

PMID:9068024
Abstract

OBJECTIVE

An association between the development of low turnover osteopathy and the form of dialysis treatment, that is, continuous ambulatory peritoneal dialysis (CAPD), has been described. To examine the effect of a year-long CAPD treatment on calcium (Ca) turnover, 12 patients were studied prior to and one year after initiation of CAPD treatment with a dialysate calcium of 1.75 mmol/L.

DESIGN

A prospective analysis.

SETTING

Academic teaching hospital dialysis unit.

PATIENTS

Twelve patients with an average age of 54.8 years (range: 23-76 years) at commencement of dialysis and after 13 months of CAPD treatment.

MEASUREMENTS

Calcium kinetic studies were performed using two calcium isotopes: 45Ca as an oral tracer and 47Ca as an intravenous tracer. Measurements of plasma and whole body activities were performed over a four-week period. From these measurements, kinetic parameters describing calcium turnover in different compartments were studied. These measurements were repeated after a mean time of 13.4 months. Patients were not treated with vitamin D, but received aluminum- and calcium-containing phosphate binders, in order to keep inorganic phosphate below 2.0 mmol/L and calcium within the normal range.

RESULTS

After one year on CAPD, serum levels of calcium increased from 2.2 mmol/L to 2.35 mmol/L. Inorganic phosphate also increased from 1.4 mmol/L to 1.9 mmol/L, despite increased use of oral phosphate binders. Serum levels of intact parathyroid hormone (IPTH) decreased from 51.2 pmol/L to 28.3 pmol/L. Alkaline phosphatase did not change, nor did serum levels of vitamin D. Despite improvement of serum IPTH levels and better control of serum calcium, the kinetic parameters describing calcium turnover in the different calcium pools did not improve. In addition, the calcium retention of bone remained below normal range and did not rise. Perhaps more importantly, the relationship between Ca efflux and Ca retention did not change. While Ca retention remained low, plasma Ca efflux was normal. This imbalance was seen at the beginning of CAPD and did not change under CAPD.

CONCLUSION

These data demonstrate that, after one year of CAPD treatment without vitamin D treatment, calcium turnover did not improve, despite a significant fall in serum IPTH levels. Studies on a larger number of patients are warranted to verify these results.

摘要

相似文献

1
Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.
Perit Dial Int. 1997 Jan-Feb;17(1):59-65.
2
Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.持续性非卧床腹膜透析中使用低钙溶液(1.0 mmol/L)进行长期透析:对骨矿物质代谢的影响。多中心研究组协作人员
Perit Dial Int. 1996 May-Jun;16(3):260-8.
3
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
4
Effect of CAPD and hemodialysis on parathyroid function.持续性非卧床腹膜透析和血液透析对甲状旁腺功能的影响。
Adv Perit Dial. 1996;12:239-44.
5
Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.使用低镁腹膜透析液的持续性非卧床腹膜透析(CAPD)患者血清甲状旁腺激素与镁水平之间的关系。
Korean J Intern Med. 2002 Jun;17(2):114-21. doi: 10.3904/kjim.2002.17.2.114.
6
A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients.一项在持续性非卧床腹膜透析(CAPD)患者中比较1.25毫摩尔/升钙透析液与1.75毫摩尔/升钙透析液的随机试验。
Nephrol Dial Transplant. 1996 Jan;11(1):88-93.
7
High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.持续性非卧床腹膜透析(CAPD)患者使用高正常钙(1.35 mmol/l)透析液:对血浆钙、磷和甲状旁腺激素进行有效且安全的长期控制
Nephrol Dial Transplant. 1996 Aug;11(8):1586-91.
8
Differences in calcium kinetic pattern between CAPD and HD patients.持续性非卧床腹膜透析(CAPD)患者与血液透析(HD)患者钙动力学模式的差异。
Clin Nephrol. 1995 Oct;44(4):255-61.
9
Low calcium dialysate and hyperparathyroidism.低钙透析液与甲状旁腺功能亢进症。
Perit Dial Int. 1996;16 Suppl 1:S499-502.
10
[Dynamic changes in calcium and phosphate plasma concentrations in the patients on peritoneal dialysis].[腹膜透析患者血浆钙和磷浓度的动态变化]
Vojnosanit Pregl. 2006 Jan;63(1):27-30. doi: 10.2298/vsp0601027j.